Tags: everolimusrenal cancerhypoxiarenal cell carcinomaanemia
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 2 months ago Novel PARP1 Inhibitor Shows Promise in Breast Cancer - 5 months ago FDA Approves Belzutifan for Advanced Renal Cell Carcinoma - 9 months ago | |
| 2 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Novel TKI Promising in Early Study of HER2-Mutant NSCLC - 3 months ago | |
| 3 | Will Norman PV Tech Senior reporter. London | ||
| 4 | Kristen Monaco MedPage Today | Once-Rejected Drug Now FDA Approved for CKD-Related Anemia - 6 months ago | |
| 5 | Shelby Bradford, PhD The Scientist Assistant Editor @TheScientistLLC. Opinions my own. | Viral Immune Responses Suppress a Gestational Hormone - 6 months ago | |
| 6 | Clare Wilson New Scientist Science news source. Worldwide | ||
| 7 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 8 | Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location | Gut-Friendlier Dose of Nintedanib Finally Backed by Some Data - 12 months ago | |
| 9 | Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom | ||
| 10 | Randy Dotinga MedPage Today Indie scribbler, advocate.
Board member, @ahcj. San Diego |